Cardiorenal syndrome (CRS) commonly occurs during treatment of acute decompensated ... or dysfunction of heart and kidney Sepsis, noncardiogenic shock AHF-ACS: Acute heart failure-acute coronary ...

allowing their usage in paediatric patients with acute decompensated heart failure (ADHF) and cardiogenic shock. The amendment of PMA specifies the use of the devices for paediatric patients who ...

KL4 Surfactant is under clinical development by Windtree Therapeutics and currently in Phase II for Coronavirus Disease 2019 (COVID-19) Associated Acute Respiratory Distress Syndrome.

Patients that show symptoms of decompensated heart failure (DHF) require immediate medical attention to take the strain off heart muscles. Failing to get treatment could worsen the condition.

Reprieve Cardiovascular, Inc., a development-stage company focused on advancing acute decompensated heart failure (ADHF) treatment, today announced the first-in-human results of the Reprieve System at ...

Data from multiple Phase 2 studies in patients with early cardiogenic shock or acute decompensated heart failure have demonstrated that istaroxime infused intravenously significantly improves cardiac ...

decompensated heart failure, cardiogenic shock, pulmonary hypertension, or hypersensitivity reactions. Rapiblyk is supplied as a lyophilized powder containing 280mg of landiolol (equivalent to ...

for use in specific pediatric patients with symptomatic acute decompensated heart failure (ADHF) and cardiogenic shock. A PMA is the highest level of approval granted by the FDA for the safety and ...

Acute cardiorenal (type 1) Acute worsening of heart function (AHF-ACS) leading to kidney injury and/or dysfunction Acute decompensated ... shock AHF-ACS: Acute heart failure-acute coronary ...